These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 3866545

  • 1. Aplastic anemia and acute leukemia: a possible relationship with sulindac therapy?
    Kiyingi A, Robertson TI, Green DG.
    Aust N Z J Med; 1985 Aug; 15(4):455-6. PubMed ID: 3866545
    [No Abstract] [Full Text] [Related]

  • 2. Marrow aplasia and sulindac.
    Miller JL.
    Ann Intern Med; 1980 Jan; 92(1):129. PubMed ID: 7350861
    [No Abstract] [Full Text] [Related]

  • 3. Sulindac-induced bone marrow toxicity.
    Sanz MA, Martinez JA, Gomis F, Garcia-Borras JJ.
    Lancet; 1980 Oct 11; 2(8198):802-3. PubMed ID: 6107481
    [No Abstract] [Full Text] [Related]

  • 4. Aplastic anemia and sulindac.
    Bennett L, Schlossman R, Rosenthal J, Balzora JD, Bennett AJ, Rosner F.
    Ann Intern Med; 1980 Jun 11; 92(6):874. PubMed ID: 7387038
    [No Abstract] [Full Text] [Related]

  • 5. Immune hemolytic anemia associated with sulindac.
    Johnson FP, Hamilton HE, Liesch MR.
    Arch Intern Med; 1985 Aug 11; 145(8):1515-6. PubMed ID: 4026480
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Aplastic anaemia, oxymetholone and acute myeloid leukaemia.
    King JB, Burns DG.
    S Afr Med J; 1972 Oct 28; 46(43):1622-3. PubMed ID: 4509114
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Hypoplastic anemia and myeloblastic leukemia following chloramphenicol therapy. Report of three cases.
    Brauer MJ, Dameshek W.
    N Engl J Med; 1967 Nov 09; 277(19):1003-5. PubMed ID: 5234404
    [No Abstract] [Full Text] [Related]

  • 12. Thrombocytopenia secondary to sulindac therapy.
    Shojania AM, Rusen SD.
    Can Med Assoc J; 1981 Dec 15; 125(12):1313. PubMed ID: 7198933
    [No Abstract] [Full Text] [Related]

  • 13. Hepatitis, toxic epidermal necrolysis and pancreatitis in association with sulindac therapy.
    Klein SM, Khan MA.
    J Rheumatol; 1983 Jun 15; 10(3):512-3. PubMed ID: 6224935
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Acute exacerbation of Parkinson's disease with sulindac.
    Sandyk R, Gillman MA.
    Ann Neurol; 1985 Jan 15; 17(1):104-5. PubMed ID: 3157343
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Nephrotic syndrome associated with sulindac.
    Lomvardias S, Pinn VW, Wadhwa ML, Koshy KM, Heller M.
    N Engl J Med; 1981 Feb 12; 304(7):424. PubMed ID: 7453761
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Sulindac and jaundice.
    Wolfe PB.
    Ann Intern Med; 1979 Oct 12; 91(4):656. PubMed ID: 484983
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.